Characteristics of O157 versus Non-O157 shiga toxin-producing escherichia coli infections in minnesota, 2000-2006

Clinical Infectious Diseases

Volumn 49, Issue 3, 2009, Pages 358-364

  Hedican, Erin B ^a,b   Medus, Carlota ^a   Besser, John M ^b   Juni, Billie A ^b   Koziol, Bonnie ^b   Taylor, Charlott ^b   Smith, Kirk E ^a  

^a Acute Disease Investigation and Control Section   (United States)

^b MINNESOTA DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN 1; VEROTOXIN 2;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOODY DIARRHEA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; ENVIRONMENTAL EXPOSURE; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FECES CULTURE; FEMALE; FEVER; GENETIC SCREENING; HEALTH MAINTENANCE ORGANIZATION; HEMOLYTIC UREMIC SYNDROME; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHILD; CHILD, PRESCHOOL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MINNESOTA; SEROTYPING; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; YOUNG ADULT;

EID: 67651091959     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/600302     Document Type: Article

References (27)

1. Griffin P, Mead P, Sivapalasingam S. Escherichia coli O157:H7 and other enterohemorrhagicE. coli. In: Blaser MJ, Smith PD, Ravdin JI, et al., eds. Infections of the gastrointestinal tract. 2nd ed: Philadelphia: Lip- pincott Williams &Wilkins, 2003:627-2.
2. Blanco J, Blanco M, Blanco J, et al. Epidemiology of verocytotoxigenic Escherichia coli (VTEC) in ruminants. In: Duffy G, Garvey P, D M, eds. Verocytotoxigenic Escherichia coli. Trumbull, CT: Food and Nutrition Press, 2001:113-48.
3. Johnson R, Clarke R, Wilson J, et al. Growing concerns and recent outbreaks involving non-O157:H7 serotypes of Verotoxigenic Escherichia coli. J Food Prot 1996;59:1112-22.
4. Banatvala N, Debeukelaer M, Griffin P, et al. Shiga-like toxin-producing Escherichia coli O111 and associated hemolytic-uremic syndrome: a family outbreak. Pediatr Infect Dis J 1996; 15:1008-11.
5. Caprioli A, Luzzi I, Rosmini F, et al. Communitywide outbreak of hemolytic-uremic syndrome associated with non-O157 Verocytotoxin- producing Escherichia coli. J Infect Dis 1994; 169:208-11.
6. Brooks J, Bergmire-Sweat D, Kennedy M, et al. Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp. Clin Infect Dis 2004; 38:190-8.
7. McCarthy T, Barrett N, Hadler J, et al. Hemolytic-uremic syndrome and Escherichia coli O121 at a lake in Connecticut, 1999. Pediatrics 2001; 108:e59-66.
8. Werber D, Fruth A, Liesegang A, et al. A multistate outbreak of Shiga toxin-producing Escherichia coli O26:H11 infections in Germany, detected by molecular subtyping surveillance. J Infect Dis 2002; 186:419-22.
9. Wickham ME, Lupp C, Mascarenhas M, et al. Bacterial genetic determinants of non-O157 STEC outbreaks and hemolytic-uremic syndrome after infection. J Infect Dis 2006; 194:819-27.
10. Tarr P, Gordon C, Chandler W. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 2005;365:1073-86.
11. Ethelberg S, Olsen K, Scheutz F, et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 2004; 10:842-7.
12. Brooks J, Sowers E, Wells J, et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 2005; 192:1422-9.
13. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201.
14. Olsvik O, Strockbine NA. PCR detection of heat-stable, heat labile, and Shiga-like toxin genes in Escherichia coli. In: Persing D, Smith T, Tenover F, et al., eds. Diagnostic molecular microbiology. Washington, DC: American Society for Microbiology Press, 1993:271-6.
15. Paton A, Paton J. Detection and characterization of Shiga toxigenic Escherichia coli by using multiplex PCR assays for stxl, stx2, eaeA, enterhemorrhagic E. coli hylA, rfbO111, and rfbO157. J Clin Microbiol 1998; 36:598-602.
16. Orskov F, Orskov I. Serotyping of Escherichia coli. In: Bergan T, ed. Methods of microbiology. Vol 14. London: Academic Press, 1984: 43-112.
17. Lockary V, Hudson R, Ball C. Shiga toxin-producing Escherichia coli, Idaho [letter]. Emerg Infect Dis 2007; 13:1262-.
18. Fey P, Wickert R, Rupp M, et al. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 2000; 6:530-3.
19. Centers for Disease Control and Prevention. Laboratory-confirmed non-O157 Shiga toxin-producing Escherichia coli-Connecticut, 2000-2005. MMWR Morb Mortal Wkly Rep 2007; 56:29-31.
20. Jelacic J, Damrow T, Chen G, et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 2003; 188:719-29.
21. Manning S, Madera R, Schneider W, et al. Surveillance for Shiga toxin- producing Escherichiacoli,Michigan. EmergInfectDis 2007; 13:318-21.
22. Kassenborg H, Hedberg C, Hoekstra M, et al. Farm visits and under- cooked hamburgers as major risk factors for sporadic Escherichia coli O157:H7 infection: data from case-control study in 5 FoodNet sites. Clin Infect Dis 2004; 38:S271-8.
23. Voetsch A, Kennedy M, Keene W, et al. Risk factors for sporadic Shi- ga toxin-producing Escherichia coli O157 infections in FoodNet sites, 1999-2000. Epidemiol Infect 2007; 135:993-1000.
24. Bielaszewska M, Friedrich AW, Aldick T, et al. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 2006; 43:1160-7.
25. Persson S, Olsen K, Ethelberg S, et al. Subtyping method for Escherichia coli Shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol 2007; 45:2020-4.
26. Orth D, Grif K, Khan A, et al. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in virto correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis 2007; 59:235-42.
27. Friedrich A, Bielaszewska M, Zhang W, et al. Escherichia coli harbouring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185:74-84.